Peripheral Artery Revascularization Market to Flourish with an Impressive 2028Posted by vakhas on July 4th, 2019 Peripheral artery disease (PAD) is a blood circulation disorder due to buildup of plaque in the arteries that supply blood to the peripheral organs such as legs, arms, and others organs apart from brain and heart. Patients with PAD are at the higher risk for major atherothrombotic events such as stroke and myocardial infarction. Peripheral artery revascularization is minimally invasive treatment to improve blood circulation with less pain and scarring, and faster recovery time. Increasing prevalence of lifestyle diseases such as obesity and diabetes associated with high cholesterol level has led to peripheral artery disease which in turn influences the development of peripheral artery revascularization market. The peripheral artery revascularization market is expected to witness a steady growth in the coming years with rising number of geriatric population across the globe. More instances of smoking, high blood pressure, and high cholesterol level on the coattails of unhealthy lifestyle habits are likely drive the peripheral artery revascularization market. Government initiatives in the development of healthcare sector along with growing awareness of new treatment methods are the major factors fuelling peripheral artery revascularization market. Adoption of innovative vascularization techniques and new technologies will possibly create potential growth prospects of peripheral artery revascularization market. Tentatively, the global peripheral artery revascularization market can be segmented on the basis of product type, procedure type, indication type, end use, and geography. Based on Procedure type, the global peripheral artery revascularization market is segmented as:
Based on Indication type, the global peripheral artery revascularization market is segmented as:
Based on end user, the global peripheral artery revascularization market is segmented as
Request/View TOC@ https://www.factmr.com/connectus/sample?flag=T&rep_id=1004 Peripheral artery revascularization Market: Overview Global peripheral artery revascularization market is expected to grow significantly over the forecast period attributing to increasing prevalence of peripheral artery disease. Increasing global geriatric population is expected to contribute significantly to peripheral artery revascularization market growth. Worldwide prevalence of peripheral artery disease is around 200 million, driving peripheral artery revascularization market growth. New technologies like stent are expected to dominate product type segment of peripheral artery revascularization market. Approximately, more than 10% people with peripheral artery disease live in the U.S. Nearly, 70% of total population affected with peripheral artery disease live in low to middle income regions. Hence, Asia-Pacific and Middle East peripheral artery revascularization market is expected to grow significantly. Regions like North America and Europe are witnessing steady growth in prevalence of peripheral artery disease which in turn leads to growth of the peripheral artery revascularization market. Peripheral artery revascularization Market: Key Players Some of the global key players operating in peripheral artery revascularization market are Boston Scientific Corporation, Abbott Laboratories, AngioDynamics, Inc., Cook Medical, Cardinal Health, Inc., C. R. Bard, Inc., The Spectranetics Corporation, Medtronic plc, Terumo Corporation. The report covers exhaustive analysis on:
Regional analysis includes
Like it? Share it! More by this author |